Travv raises $1.6M to build AI-powered veterinary diagnostics

What's the deal? TravvDealroom has a profile for this one. Try Dealroom →, a Stillwater, Oklahoma-based startup building an AI-native diagnostic platform for veterinary medicine, has closed a $1.6M seed round led by Digitalis VenturesDealroom has a profile for this one. Try Dealroom →, with AniVCDealroom has a profile for this one. Try Dealroom → completing the financing.

The funding will support product development, hospital onboarding, commercial growth, and key integrations. Travv is focused initially on radiology workflows, with a longer-term vision for broader AI-enabled diagnostic services.

"Veterinary diagnostics needs better infrastructure," said Derick Whitley, founder and chief executive officer of Travv. "We're building Travv to create a seamless experience for both hospitals and diagnosticians, while laying the foundation for the next generation of diagnostic tools."

Why now? Veterinary medicine is increasingly seen as ripe for AI disruption, particularly in diagnostics where workflow bottlenecks and specialist shortages create real demand for automation. Travv is positioning itself as foundational infrastructure — not just another AI tool — for the sector.

"Travv is building in an area of veterinary medicine that is primed for AI," said Cindy Cole of Digitalis Ventures. "We're excited to support Dr. Whitley and the team as they build an integrated diagnostic platform with the potential to improve workflow today and enable broader innovation over time."

What could go wrong? At $1.6M, the round is modest. Travv will need to demonstrate traction quickly to attract follow-on funding in a competitive landscape where larger players could move into veterinary AI diagnostics. Regulatory considerations around AI in clinical settings — even in animal medicine — could also slow adoption.

The signal: The investor mix here is telling — Digitalis Ventures is a dedicated life-sciences fund, while AniVC is a corporate investor, suggesting strategic as well as financial backing for Travv's early growth phase. With veterinary tele-diagnostics still lacking consolidated infrastructure, the combination of specialist capital and industry connections could help Travv embed itself into hospital workflows before better-funded horizontal AI players turn their attention to the space.

Read more: ces.einnews.com